ArticleMedComm2025

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer.

Yunfang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.